HomeCompareCLVS vs MCD

CLVS vs MCD: Dividend Comparison 2026

CLVS yields 2463.05% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLVS wins by $70041530665.24M in total portfolio value
10 years
CLVS
CLVS
● Live price
2463.05%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$70041530665.32M
Annual income
$64,861,296,013,860,630.00
Full CLVS calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — CLVS vs MCD

📍 CLVS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLVSMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLVS + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLVS pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLVS
Annual income on $10K today (after 15% tax)
$209,359.61/yr
After 10yr DRIP, annual income (after tax)
$55,132,101,611,781,540.00/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, CLVS beats the other by $55,132,101,611,759,240.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLVS + MCD for your $10,000?

CLVS: 50%MCD: 50%
100% MCD50/50100% CLVS
Portfolio after 10yr
$35020765332.70M
Annual income
$32,430,648,006,943,428.00/yr
Blended yield
92.60%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

CLVS
Analyst Ratings
11
Buy
10
Hold
4
Sell
Consensus: Buy
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLVS buys
0
MCD buys
0
No recent congressional trades found for CLVS or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLVSMCD
Forward yield2463.05%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$70041530665.32M$78.5K
Annual income after 10y$64,861,296,013,860,630.00$26,227.70
Total dividends collected$69679216448.03M$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: CLVS vs MCD ($10,000, DRIP)

YearCLVS PortfolioCLVS Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$257,005$246,305.42$10,815$334.85+$246.2KCLVS
2$6,191,054$5,916,058.62$11,826$491.71+$6.18MCLVS
3$139,814,248$133,189,820.21$13,123$730.06+$139.80MCLVS
4$2,960,686,816$2,811,085,570.49$14,853$1,100.07+$2960.67MCLVS
5$58,800,787,025$55,632,852,131.69$17,257$1,690.61+$58800.77MCLVS
6$1,095,531,336,986$1,032,614,494,869.48$20,752$2,667.01+$1095531.32MCLVS
7$19,152,484,228,807$17,980,265,698,231.36$26,103$4,354.83+$19152484.20MCLVS
8$314,266,670,684,876$293,773,512,560,052.56$34,794$7,437.78+$314266670.65MCLVS
9$4,841,340,795,759,426$4,505,075,458,126,609.00$49,926$13,461.60+$4841340795.71MCLVS
10$70,041,530,665,323,210$64,861,296,013,860,630.00$78,550$26,227.70+$70041530665.24MCLVS

CLVS vs MCD: Complete Analysis 2026

CLVSStock

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the company offers Rubraca for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is also developing lucitanib, an investigational angiogenesis inhibitor, which inhibits vascular endothelial growth factor receptors 1 through 3 (VEGFR 1-3), platelet-derived growth factor receptors alpha and beta (PDGFRa/ß), and fibroblast growth factor receptors 1 through 3 (FGFR 1-3);and FAP-2286, an investigational peptide-targeted radionuclide therapy and imaging agent targeting fibroblast activation protein. In addition, the company sells its Rubraca through a limited number of specialty distributor and specialty pharmacy providers, who subsequently sells Rubraca to patients and health care providers. Clovis Oncology, Inc. has license agreements with Pfizer Inc., AstraZeneca UK Limited, Advenchen Laboratories LLC, and 3B Pharmaceuticals GmbH, a clinical collaboration with Bristol Myers Squibb Company; and a partnership with Foundation Medicine, Inc. Clovis Oncology, Inc. was incorporated in 2009 and is headquartered in Boulder, Colorado. On December 11, 2022, Clovis Oncology, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full CLVS Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this CLVS vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLVS vs SCHDCLVS vs JEPICLVS vs OCLVS vs KOCLVS vs MAINCLVS vs YUMCLVS vs QSRCLVS vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.